rs141304623

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000545.8(HNF1A):​c.1722C>A​(p.Ser574Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,612,424 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S574D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00093 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00010 ( 1 hom. )

Consequence

HNF1A
NM_000545.8 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications B:5O:1

Conservation

PhyloP100: 1.41

Publications

1 publications found
Variant links:
Genes affected
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
HNF1A Gene-Disease associations (from GenCC):
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • type 1 diabetes mellitus 20
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young type 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • hyperinsulinism due to HNF1A deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonpapillary renal cell carcinoma
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011299312).
BP6
Variant 12-120999581-C-A is Benign according to our data. Variant chr12-120999581-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 393435.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000925 (141/152354) while in subpopulation AFR AF = 0.00329 (137/41590). AF 95% confidence interval is 0.00284. There are 1 homozygotes in GnomAd4. There are 72 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 141 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNF1ANM_000545.8 linkc.1722C>A p.Ser574Arg missense_variant Exon 9 of 10 ENST00000257555.11 NP_000536.6 P20823E0YMI7
HNF1ANM_001306179.2 linkc.1743C>A p.Ser581Arg missense_variant Exon 9 of 10 NP_001293108.2 P20823E0YMI7
HNF1ANM_001406915.1 linkc.1530C>A p.Ser510Arg missense_variant Exon 8 of 9 NP_001393844.1
HNF1AXM_024449168.2 linkc.1815C>A p.Ser605Arg missense_variant Exon 8 of 9 XP_024304936.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNF1AENST00000257555.11 linkc.1722C>A p.Ser574Arg missense_variant Exon 9 of 10 1 NM_000545.8 ENSP00000257555.5 A0A0A0MQU7

Frequencies

GnomAD3 genomes
AF:
0.000926
AC:
141
AN:
152236
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00330
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000243
AC:
59
AN:
242772
AF XY:
0.000121
show subpopulations
Gnomad AFR exome
AF:
0.00352
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000103
AC:
150
AN:
1460070
Hom.:
1
Cov.:
35
AF XY:
0.0000771
AC XY:
56
AN XY:
726378
show subpopulations
African (AFR)
AF:
0.00406
AC:
136
AN:
33470
American (AMR)
AF:
0.000134
AC:
6
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26100
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86208
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52306
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5626
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111680
Other (OTH)
AF:
0.0000995
AC:
6
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000925
AC:
141
AN:
152354
Hom.:
1
Cov.:
33
AF XY:
0.000966
AC XY:
72
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.00329
AC:
137
AN:
41590
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00121
Hom.:
0
Bravo
AF:
0.00103
ESP6500AA
AF:
0.00251
AC:
11
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000297
AC:
36

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Benign:5Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 05, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Maturity onset diabetes mellitus in young Benign:1Other:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Uncertain risk allele
Review Status:criteria provided, single submitter
Collection Method:research

Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs141304623 with MODY3. -

Sep 13, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Monogenic diabetes Benign:1
Nov 10, 2015
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG Criteria: PP3, BS2 (type2diabetesgenetics.org), BP4 -

HNF1A-related disorder Benign:1
May 07, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.53
.;D;.;T;.
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.27
T;T;T;T;T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.011
T;T;T;T;T
MetaSVM
Benign
-0.39
T
PhyloP100
1.4
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-1.1
N;.;.;N;N
REVEL
Uncertain
0.38
Sift
Benign
0.048
D;.;.;D;T
Sift4G
Benign
0.46
T;T;T;T;T
Polyphen
0.018
.;.;.;.;B
Vest4
0.25
MutPred
0.44
.;.;.;.;Loss of glycosylation at S581 (P = 0.0238);
MVP
0.84
MPC
0.14
ClinPred
0.056
T
GERP RS
2.4
gMVP
0.43
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141304623; hg19: chr12-121437384; API